ReviewExpert opinion on therapeutic targets2022

The α9α10 nicotinic acetylcholine receptor: a compelling drug target for hearing loss?

Ana Belén ElgoyhenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.